• AI
  • Molecular Imaging
  • CT
  • X-Ray
  • Ultrasound
  • MRI
  • Facility Management
  • Mammography

Nycomed names new chairman

Article

Nycomed Amersham this month named a new chairman, sparking speculation that the company’s Norwegian influence is decreasing. Richard Lapthorne, Nycomed’s deputy chairman, will trade jobs with chairman Johan Odfjell at the conclusion of the

Nycomed Amersham this month named a new chairman, sparking speculation that the company’s Norwegian influence is decreasing. Richard Lapthorne, Nycomed’s deputy chairman, will trade jobs with chairman Johan Odfjell at the conclusion of the firm’s annual general meeting on May 6. Odfjell was appointed chairman when Nycomed and Amersham merged into a $2.5 billion drug company in October 1997 (SCAN 7/9/97 and 10/29/97). The Buckinghamshire, U.K., and Oslo, Norway, company also announced that its executive director, Tore Laerdal, will retire after the meeting.

At the time of the merger, the two companies took care to balance the new entity’s executive lineup between U.K. and Norwegian officers. But industry experts wonder if the company is gradually leaning toward Buckinghamshire. Lapthorne and Odfjell’s switch is the latest in a series of personnel shifts in which many Norway-based executives have left the company.

Related Videos
Improving the Quality of Breast MRI Acquisition and Processing
Can Fiber Optic RealShape (FORS) Technology Provide a Viable Alternative to X-Rays for Aortic Procedures?
Does Initial CCTA Provide the Best Assessment of Stable Chest Pain?
Making the Case for Intravascular Ultrasound Use in Peripheral Vascular Interventions
Can Diffusion Microstructural Imaging Provide Insights into Long Covid Beyond Conventional MRI?
Assessing the Impact of Radiology Workforce Shortages in Rural Communities
Emerging MRI and PET Research Reveals Link Between Visceral Abdominal Fat and Early Signs of Alzheimer’s Disease
Reimbursement Challenges in Radiology: An Interview with Richard Heller, MD
Nina Kottler, MD, MS
The Executive Order on AI: Promising Development for Radiology or ‘HIPAA for AI’?
Related Content
© 2024 MJH Life Sciences

All rights reserved.